🇺🇸

US SEC Filing Intelligence

· daily

Significant Contract Modifications ($10M+) — May 31, 2026

This digest covers a single large civilian agency contract modification totaling $272.8 million, awarded to General Dynamics Information Technology (GDIT) by the General Services Administration (GSA) FAS FEDSIM for IT services supporting SOF enterprise capabilities. The contract is cost-plus-fixed-fee, indicating lower profit upside but reduced execution risk, and includes a potential total value of $364.1 million with options. Notably, the award carries a negative outlayed amount of -$212K, suggesting possible prior funding adjustments or accounting anomalies. The highest-conviction signal is neutral given GDIT’s entrenched position in defense IT services, but investors should watch for option exercises and any funding corrections. A key risk is the negative outlayed amount, which could signal execution or budget issues despite the contract’s size.

1 total filings
· daily

Contract Option Exercises — May 31, 2026

The single contract analyzed for the period of May 31, 2026, is a $272.8 million cost-plus-fixed-fee delivery order awarded to General Dynamics Information Technology by the General Services Administration’s FEDSIM division, supporting IT services for SOF enterprise capabilities at Fort Bragg. This is a civilian-administered contract (GSA), not a direct defense award, making it a neutral signal for the defense sector. The dominant theme is sustained federal investment in IT modernization and enterprise architecture, with General Dynamics’ position reinforced. Key risks include the unusual negative outlayed amount (-$212K) suggesting prior funding adjustments, and cost-plus pricing which caps profit upside. The highest-conviction signal is the contract’s large potential value ($364.1M including options), providing multi-year revenue visibility for General Dynamics Information Technology, but with low pricing risk and no clear competitive moat.

1 total filings
· daily

Federal IT & Cybersecurity Contracts — May 31, 2026

This digest covers a single, large civilian contract from the General Services Administration (GSA) to General Dynamics Information Technology (GDIT) valued at $272.8 million obligated, with a potential $364.1 million including options. The award is for IT services supporting SOF enterprise capabilities at Fort Bragg, NC, and is a cost-plus-fixed-fee delivery order under full and open competition. The neutral signal strength (6/10) and a negative outlayed amount (-$212K) introduce caution, despite the multi-year revenue visibility. The key risk is the unusual negative outlay, which may indicate prior funding adjustments or execution issues, while the key watch item is the exercise of options to confirm program continuity.

1 total filings
· daily

Mega Contracts Monitor ($100M+) — May 31, 2026

This single-contract digest covers a $272.8 million cost-plus-fixed-fee delivery order awarded to General Dynamics Information Technology (GDIT) by the General Services Administration's FAS FEDSIM for IT services supporting SOF enterprise capabilities at Fort Bragg. The award is entirely civilian-facing (GSA) but supports defense end-users, creating a hybrid signal. The neutral signal strength (6/10) and low materiality (5/10) reflect a large but routine IT services renewal with no competitive moat or set-aside advantage. Key watch items include the negative outlayed amount (-$212K) suggesting prior funding adjustments, and the cost-plus pricing structure that caps profit upside. No bullish or bearish signals are generated from this single award.

1 total filings
· daily

High-Value Federal Grants ($5M+) — May 31, 2026

This digest covers a single high-value federal grant from the General Services Administration (GSA) to General Dynamics Information Technology (GDIT) for $272.8 million in obligated IT services supporting SOF enterprise capabilities at Fort Bragg, NC. The award is civilian-administered (GSA FAS FEDSIM) but defense-aligned, reinforcing GDIT’s position in the defense IT services market. The contract uses cost-plus-fixed-fee pricing, which lowers profit risk but limits upside versus fixed-price work. Key risks include an unusual negative outlayed amount (-$212K) suggesting prior funding adjustments or cancellations, and a 2025 expiration that creates re-compete uncertainty. No other bullish or bearish signals were identified in this single-record period.

1 total filings
· daily

Biotech Small-Cap Approvals — May 30, 2026

The May 30, 2026, small-cap biotech approval stream delivered zero high-value events—no NMEs, biosimilars, or label expansions—and five 'FALLBACK' designations for generic/biosimilar versions of established molecules. The approvals are uniformly neutral in signal, with no therapeutic area clustering beyond generic drug categories. The highest-conviction signal is the absence of any breakthrough or priority review designation, indicating no near-term commercial catalysts for small-cap sponsors. Key risk: these approvals represent low-margin, commoditized market entries with no disclosed peak sales, exclusivity, or pricing power, offering minimal differentiation for investors. The period lacks any IRA exposure flags or accelerated approval risks, as all drugs are off-patent generics.

5 total filings
· daily

New Drug Approvals (Original) — May 30, 2026

The May 30, 2026 approval stream is entirely composed of five generic/biosimilar approvals (0 NMEs, 0 biosimilars as defined by the FDA, 0 label expansions, 5 'Other' fallback approvals). The period lacks any high-value NME or breakthrough therapy catalysts, resulting in a neutral signal across the board. The dominant theme is generic market entry for established small molecules (hydrochlorothiazide, carboprost tromethamine, L-glutamine, levalbuterol hydrochloride, topiramate) by sponsors including Hetero Labs Ltd V, Somerset Therapeutics LLC, Annora Pharma, Nephron, and Riconpharma LLC. The highest-conviction signal is the lack of any novel therapeutic innovation, which underscores a quiet period for biotech catalysts but reinforces the steady-state generic erosion dynamics in mature drug classes. Key risk: no IRA-exposure flags or accelerated approval risks are triggered, but the absence of NMEs means no new pipeline signals for institutional investors to act on.

5 total filings
· daily

DHS Homeland Security Contracts — May 30, 2026

The two DHS contracts totaling $526.4 million are entirely civilian, with no defense exposure, and are dominated by a single $443.1M border wall construction award to Sundt Construction, Inc. This award, representing 84% of the total obligation, signals a renewed DHS/CBP focus on physical infrastructure at the southwest border, creating a high-conviction near-term revenue opportunity for Sundt. The second award, an $83.3M TSA telecom contract to AT&T Enterprises, underscores ongoing civilian IT modernization but carries execution risk from a prior stop-work order. Key risks include fixed-price execution pressure on Sundt and potential budget uncertainty from a Continuing Resolution affecting DHS civilian spending.

2 total filings
· daily

Significant Contract Modifications ($10M+) — May 30, 2026

This digest covers $907.9M in obligations across 5 civilian contracts (0 defense-related), dominated by a single $443M DHS/CBP border wall award to Sundt Construction. The highest-conviction signal is Sundt's competitive win for southwest border infrastructure, implying ~$197M annual revenue potential through 2028, though the fixed-price structure and zero outlayed to date carry execution risk. A second DHS award to AT&T Enterprises ($83.3M obligated, $415M potential) for TSA telecom services reinforces civilian IT modernization spending. The remaining awards to Caddell Construction (State Dept, $236M, 2016 vintage), Lantana Consulting (CDC, $81.5M), and ESIMPLICITY (CMS, $63.5M) are neutral signals due to age or small-business concentration. Key risk: Sundt's border wall contract faces political and budget uncertainty given DHS's shifting priorities and potential CR impacts on new-start construction projects.

5 total filings
· daily

Contract Deobligations Alert — May 30, 2026

With $907.9 million in total obligations across 5 contracts and zero defense-related awards, this digest signals a pronounced civilian-agency spending cycle, dominated by a single $443M DHS/CBP border wall award to SUNDT CONSTRUCTION. The highest-conviction signal is SUNDT's competitive win, implying near-term revenue of ~$197M annually for a construction firm, offset by fixed-price execution risk on a politically sensitive project. Civilian IT modernization remains active—AT&T's $415M TSA telecom deal and CMS's $63.5M Salesforce BPA highlight stable demand for telecom and cloud services, though budget uncertainty under continuing resolutions and HHS funding debates poses downside risk. The digest's neutral-to-bullish tilt masks a lack of defense exposure, making this cohort a pure civilian-sector play with concentration risk in DHS border infrastructure and HHS health IT.

5 total filings
· daily

Contract Option Exercises — May 30, 2026

This digest covers $907.9 million in civilian contract obligations from May 2026, with zero defense-related awards. The dominant agency is DHS ($526M), driven by Sundt Construction's $443M border wall contract and AT&T Enterprises' $83M telecom award, signaling sustained investment in border security and enterprise IT. HHS accounts for $144M via Lantana Consulting's CDC health analytics contract and eSimplicity's CMS Salesforce/API support. The highest-conviction signal is Sundt's competitive win, though its fixed-price structure and political sensitivity around border wall funding introduce execution and budget risk. Notably, the Caddell Construction $236M State Department consulate contract is from 2016 with performance ended in 2019, providing no current revenue visibility.

5 total filings
· daily

Federal IT & Cybersecurity Contracts — May 30, 2026

The two contracts in this digest total $145.0 million in obligations, both awarded by the Department of Health and Human Services (HHS) with zero defense-related content, underscoring a civilian health IT theme. The largest award is an $81.5 million firm-fixed-price delivery order to Lantana Consulting Group for CDC adverse drug event surveillance analytics, with $52.5 million already outlayed, signaling strong execution and low cancellation risk. The second award is a $63.5 million BPA call to ESIMPLICITY Inc for Salesforce and API development support at CMS, with potential total value of $193.3 million through 2029, though future orders depend on agency needs. The highest-conviction signal is the sustained federal investment in health data analytics and IT modernization, but a key risk is that both contracts are fixed-price, transferring cost risk to contractors, and ESIMPLICITY's BPA structure introduces option execution uncertainty.

2 total filings
· daily

All HHS Contracts — May 30, 2026

Two civilian HHS contracts totaling $145 million were awarded to small businesses for health data analytics and IT modernization, reinforcing steady federal investment in public health surveillance and digital transformation. The largest award, $81.5 million to Lantana Consulting Group for CDC adverse drug event surveillance, shows strong execution with $52.5 million already outlayed, providing multi-year revenue visibility. The second award, $63.5 million to ESIMPLICITY Inc for CMS Salesforce/API development, carries upside potential up to $193.3 million through 2029 but depends on option exercises. Both contracts are firm-fixed-price with low execution risk, though neither is defense-related, limiting exposure to Pentagon budget tailwinds. Key risks include HHS budget uncertainty under continuing resolutions and option-year funding decisions for ESIMPLICITY's BPA call.

2 total filings
· daily

Mega Contracts Monitor ($100M+) — May 30, 2026

The two contracts in this digest total $679.5 million in obligations, with zero defense-related awards, signaling a civilian-heavy procurement period dominated by Department of Homeland Security (DHS) and Department of State infrastructure spending. The highest-conviction signal is Sundt Construction's $443.1 million firm-fixed-price delivery order for southwest border wall construction, a competitive win under full-and-open competition that implies near-term revenue of ~$197M annually through August 2028. However, the fixed-price structure transfers cost risk to Sundt, and the contract's zero outlayed amount indicates no revenue recognized yet, creating execution risk. The second award, Caddell Construction's $236.4 million consulate compound project in Saudi Arabia, is a legacy contract from 2016 with high overseas performance risk and no current revenue stream, making it a neutral signal for investors. Key watch items include Sundt's quarterly earnings for revenue recognition and DHS budget trends for border security infrastructure.

2 total filings
· daily

High-Value Federal Grants ($5M+) — May 30, 2026

This digest covers $907.9M in total obligations across five civilian-agency contracts, with zero defense-related awards. The dominant theme is infrastructure and IT modernization, led by a $443M DHS/CBP border wall contract to SUNDT CONSTRUCTION (materiality 8/10) and a $236M State Department consulate compound award to CADDELL CONSTRUCTION. The highest-conviction signal is the SUNDT border wall award, which represents a competitive win for a large non-small business with ~$197M annual revenue potential, though the fixed-price structure carries execution risk. A key risk is the aged CADDELL contract (2016 award, completed 2019) which provides no current revenue visibility. Civilian IT services contracts to AT&T ($83.3M obligated, TSA telecom) and ESIMPLICITY ($63.5M obligated, CMS Salesforce/API) show sustained federal digital transformation spending, but the aggregate 0/5 defense split underscores a lack of DOD exposure in this batch.

5 total filings